Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynura pseudochina var. hispida
- Development stage
- Unknown
- Administration
- Topical, Oral
01
Overview
Gynura pseudochina var. hispida is a medicinal plant from the Asteraceae family traditionally used in Thailand for treating chronic and acute inflammation. It contains bioactive compounds that inhibit the NF-κB pathway and suppress pro-inflammatory cytokines. The plant has demonstrated clinical efficacy in treating mild to moderate psoriasis with minimal side effects, comparable to 0.1% triamcinolone cream. However, caution is advised due to potential presence of hepatotoxic pyrrolizidine alkaloids.
- Other names
- Gynura pseudochina DC. var. hispida Thv.Gynura pseudochina (L.) var. hispida Thv.
02
Targets
NF-κBIL1B (Interleukin-1 beta)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Gynura pseudochina var. hispida.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gynura pseudochina var. hispida.